Barriers to and facilitators of success for early and Mid‐Career professionals focused on bipolar disorder: A global needs survey by the International Society for Bipolar Disorders

Abstract

AbstractIntroductionThe International Society for Bipolar Disorders created the Early Mid‐Career Committee (EMCC) to support career development of the next generation of researchers and clinicians specializing in bipolar disorder (BD). To develop new infrastructure and initiatives, the EMCC completed a Needs Survey of the current limitations and gaps that restrict recruitment and retention of researchers and clinicians focused on BD.MethodsThe EMCC Needs Survey was developed through an iterative process, relying on literature and content expertise of workgroup members. The survey included 8 domains: navigating transitional career stages, creating and fostering mentorship, research activities, raising academic profile, clinical‐research balance, networking and collaboration, community engagement, work‐life balance. The final survey was deployed from May to August 2022 and was available in English, Spanish, Portuguese, Italian, and Chinese.ResultsThree hundred participants across six continents completed the Needs Survey. Half of the participants self‐identified as belonging to an underrepresented group in health‐related sciences (i.e., from certain gender, racial, ethnic, cultural, or disadvantaged backgrounds including individuals with disabilities). Quantitative results and qualitative content analysis revealed key barriers to pursuing a research career focused on BD with unique challenges specific to scientific writing and grant funding. Participants highlighted mentorship as a key facilitator of success in research and clinical work.ConclusionThe results of the Needs Survey are a call to action to support early‐ and midcareer professionals pursuing a career in BD. Interventions required to address the identified barriers will take coordination, creativity, and resources to develop, implement, and encourage uptake but will have long‐lasting benefits for research, clinical practice, and ultimately those affected by BD.